Institute Home Business Roundtable Institute for Corporate Ethics Logo Business Roundtable Institute for Corporate Ethics Banner Spacer Darden Home Business Roundtable Home Institute Home
About the Business Roundtable Institute for Corporate Ethics Business Ethics Seminars Academic Advisors of the Business Roundtable Institute for Corporate Ethics Advisory Council of the Business Roundtable Institute for Corporate Ethics Business Ethics Publications Business Ethics Research Media Kit for the Business Roundtable Institute for Corporate Ethics Business Roundtable Institute for Corporate Ethics News Business Ethics Resources
spacer
In the News
 


>>>Institute News Releases 
l  Media Kit

2004 | 2005 | 2006 | 2007 | 2008 | 2009

>> Jan | Feb | Mar | Apr | May | June | July | Aug | Sep | Oct

October, 2009

Hirtle Callaghan CEO Jonathan Hirtle to Speak on Ethics Panel in New York Tonight

NewsBlaze, October 27, 2009  
 

WEST CONSHOHOCKEN, Pa. - (BUSINESS WIRE) - Jonathan Hirtle, CEO of Hirtle, Callaghan & Co., one of the nation's largest and fastest-growing privately held investment firms, will participate in a panel discussion on ethics this evening in New York. Organized by Penn State's Smeal College of Business, the discussion will examine integrity and professionalism in turbulent economic times.

[Among the] Other panelists [is] Linda Trevino, Distinguished Professor of Organizational Behavior and Ethics, Smeal College of Business.

Professor Freeman discusses ethics and profits

ABC News Australia, October 20, 2009  
 

As the big global investment banks return to profit, bonuses are paid again while political leaders call for restraint, what role do ethics play in today's business world? Joining Lateline Business is Professor Ed Freeman, who is usually based at the Darden School of Business at the University of Virginia in the US, and is currently visiting Australia as the gourley Professor of Ethics at Melbourne University.

A Cruise, a Terminal Illness and a Technicality

Ocala Star-Banner, October 11, 2009
By
David Segal
 

Q. Last year, I booked an eight-day trip to Europe for me and my brother, Stephen, who has been diagnosed with terminal cancer. ... We spent about $7,000 on the trip, a price that included $264 travel insurance, recommended by the travel agent in case Stephen had to cancel.

 A few days before the flight, he had a recurrence of a gastrointestinal ailment that is a side effect of his illness. We canceled our trip, but after we submitted paperwork for the insurance claim, the company that sold us the policy, CSA Travel Protection, said it would not return any of our money. The reason: Stephen had not seen a doctor, in person, to confirm that he’d actually been sick.

Two business school ethics professors contacted for this column found nothing to fault in CSA’s conduct, although a third, Thomas Donaldson of the Wharton School of Business of the University of Pennsylvania, described that conduct as “legal but blatantly unethical.”

(Also appeared in the New York Times, Lakeland Ledger, Wilmington Morning Star, Gainesville Sun, and Gadsden Times.)

Trust and Short-Termism    

Frontline, October 2009
By Brian Moriarty
  Too great a focus on short-term financial performance has become a burning issue in corporate ethics as it undoubtedly contributed to the economic crisis. Brian Moriarty assesses the implications.

 
 
   

2004 | 2005 | 2006 | 2007 | 2008 | 2009
 
>> Jan | Feb | Mar | Apr| May | June | July | Aug | Sep | Oct      

 


 


 

 


 


 

 

 

 

 

 

 

    

 


 


 

 

 

 

 

 

 

 


Copyright © 2005 Business Roundtable Institute for Corporate Ethics
Questions?  Contact Brian Moriarty